Health Condition 1: D539- Nutritional anemia, unspecified
Conditions
Interventions
Intervention1: Itrifal Fauladi: Dosage form:Itrifal (Semisolid)
Dose: 7gm once daily
Mode of administration: Oral
Composition of Itrifal Fauladi :
1.Amla (Emblic officinalis)
2.Namak-e-Sang(Rock sal
Sponsors
National Research Institute of Unani Medicine for Skin Disorders.
Eligibility
Inclusion criteria
Inclusion criteria: The following participants will be included in the study: 1 Participants in the age group of 18-60 years of either gender having any of the following signs and symptoms. Pallor Weakness and Fatigue Dyspnea Palpitation Anorexia Angular Stomatitis and Glossitis Oedema Koilonychia (Spoon Shaped Nail) Dizziness Fainting 2 Heamoglobin: Male, >8.0 gm% & Female, >7.0 gm% & < 12.0gm%
Exclusion criteria
Exclusion criteria: The following patients will be excluded from the study: 1 Participants aged 60years of age. 2 Participants with haemoglobin 13 gm% in Males where as & >12.0 gm% in Female. 3 History of acute blood loss, chronic diseases requiring long term treatment. 4 Pregnant and lactating women were excluded. 5 Known case of significant Pulmonary/ Cardiovascular/ Hepatorenal Dysfunction/ Malignancy/ HIV Infection /AIDS etc . 6 Known allergy to herbal drugs. 7 Those who are unwilling to come for regular follow up for the entire duration of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Hb(gm/dl) at 12 weeks from base lineTimepoint: 84 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Improvement in signs & symptoms 2) Change in Reticulocyte Count, S.Ferritin level, RBC Count, PCV, MCV, MCH,MCHC.Timepoint: 84 days | — |
Countries
India
Contacts
Public ContactDr Kahkashan Bano
National Research Institute of Unani Medicine for Skin Disorders
Outcome results
None listed